Pharma Industry Wants Easier Access To England’s Revamped NHS Data Sharing System

The pharmaceutical industry was not sufficiently involved in designing updates to England’s health data infrastructure, leading to a “misalignment” between company needs and what is currently being delivered, according to the results of a survey by the Association of the British Pharmaceutical Industry.

A better data sharing infrastructure is needed in the UK, pharma trade associations say (Shutterstock)
Quick Facts
  • Existing methods of sharing National Health Service data in the UK need to be amended to meet the needs of pharmaceutical researchers.

Health data from National Health Service (NHS) patients in England can help drugmakers to discover and develop medicines as well as conduct postmarket authorization studies and monitor the safety of drugs.

However, access to data for research purposes can be “slow and inefficient,” despite recent investments in England’s health data infrastructure,...

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Pink Sheet for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required

More from R&D

More from Advanced Technologies